Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who Clinically confirmed T2DM. Patients with HbA1C above 6.5 percentage to 7 percentage Fasting plasma glucose greater than or equal to 126 mg/dl and 2-hour PPPG greater than or equal to 200 mg/dl Patients willing to participate and giving informed consent.
Exclusion criteria
Exclusion criteria: Patients with HbA1C is more than 7 percentage Pregnant and lactating mothers. Patients with other comorbidities such as Type I Diabetes, Hypertension, Bronchial Asthma, Tuberculosis, Renal diseases, Meningitis, Hepatitis, Carcinoma and other major illnesses. Patients with a history of trauma. participants currently undergoing treatment from other systems of medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c level is reduced 1 to 1.5 % will be expected after completion of study which will be measured by before and after blood investigations.Timepoint: before treatment, 90th and 180th day of trial period | — |
Secondary
| Measure | Time frame |
|---|---|
| NIlTimepoint: Nil | — |
Countries
India
Contacts
Siddha Clinical Research Unit